AUTL AUTOLUS THERAPEUTICS PLC Management Changes 8-K Filing 2024 - Management Change Autolus Therapeutics plc announced the appointment of Matthias Will, M.D. as Chief Development Officer, effective September 30, 2024.Get access to all SEC 8-K filings of the AUTOLUS THERAPEUTICS PLC